Oncology
Breast Cancer Radiation De-Escalation Has an Adherence Problem
Real-world data presented at ASTRO show that fewer than three in ten women remained adherent to endocrine therapy over five years after lumpectomy, and omission of radiotherapy was associated with poorer adherence. De-escalation works only if the treatment patients are supposed to keep taking is actually taken.
In Australia, Cancer Medicine Delays Cost More Than Time
BRCA Care Cannot Start at Diagnosis
The Money Is Moving Into Cancer Screening. The Evidence Still Has to Catch Up.
Europe Opens Another Lung Cancer Door to China-Origin Immunotherapy
In Australia, Cancer Medicine Delays Cost More Than Time
Cancer Progress Still Depends on Your Postcode
AI genomics market set to hit $9.3B by 2030, but regulation and equity gaps remain unresolved
Japan Approves MRD Testing. Price Will Decide Whether Patients Can Use It.
The Biomarker Test Cannot Wait Until Relapse
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
Diseases in Oncology
Explore disease data and country profiles on the IPM Alliance platform.
Explore diseases